XOMA Corporation

NASDAQ XOMAO

Data sourced from iex and EODHD
Download Data

XOMA Corporation Free Cash Flow Margin 5 year CAGR for the Trailing 12 Months (TTM) ending March 31, 2024

XOMA Corporation Free Cash Flow Margin 5 year CAGR is NA for the Trailing 12 Months (TTM) ending March 31, 2024. The Free Cash Flow Margin measures the percentage of revenue that is converted into free cash flow. It indicates the company's ability to generate cash flow from its operations after accounting for capital expenditures. A higher margin suggests better cash flow generation and potential for reinvestment or distribution to shareholders. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • XOMA Corporation Free Cash Flow Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -6.94.
NASDAQ: XOMAO

XOMA Corporation

CEO -
IPO Date April 12, 2021
Location United States
Headquarters 2200 Powell Street, EmeryVille, CA, United States, 94608
Employees 13
Sector Healthcare
Industry Biotechnology
Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

XOMAP

XOMA Corp

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email